Ibrutinib Impurity 70
- CAS2142634-18-0
- CatalogueRS-I024590
- FormulaC31H35N9O4
- MW597.67
On this page
Custom synthesis — structure on request
Product identification
| Product name | Ibrutinib Impurity 70 |
|---|---|
| Catalogue No. | RS-I024590 |
| CAS No. | 2142634-18-0 |
| Molecular formula | C31H35N9O4 |
| Molecular weight | 597.67 |
| Exact mass | 597.2812 (monoisotopic) |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | Reference Standards |
| Drug substance | Ibrutinib |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-I024590 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Ibrutinib
- Standards by type (all categories)
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-I024590
- Request a quotation for RS-I024590
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Ibrutinib
All 147 further standards are on this page — 20 shown at first, then 20 more per click on Load more.
Ibrutinib
IN STOCKRS-I005030(S)-Ibrutinib
IN STOCKRS-I011151(2e)-1-(3-hydroxypiperidin-1-yl)-3-phenylprop-2-en-1-one
BACK ORDERRS-U008806(R)-1-(3-Hydroxypiperidin-1-yl)prop-2-en-1-one
IN STOCKRS-I024351(R)-1-Boc-3-hydroxypiperidine
IN STOCKRS-C031006(R)-1-N-Boc-3-Methanesulfonyloxypiperidine
BACK ORDERRS-U080774(R)-N-(3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1Hpyrazolo[
BACK ORDERRS-I009332(S)-1-(3-Hydroxypiperidin-1-yl)prop-2-en-1-one
IN STOCKRS-U079101(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
BACK ORDERRS-U079100(S)-tert-butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate
IN STOCKRS-C0500531-(3-Hydroxypiperidin-1-yl)prop-2-en-1-one
CUSTOM SYNTHESISRS-I0243521-BOC-4-hydroxypiperidine
IN STOCKRS-U0051212-(4-Phenoxybenzoyl)malononitrile
IN STOCKRS-P0173262-Phenoxybenzoic Acid
IN STOCKRS-C0060183-Methoxypropanoyl Chloride
IN STOCKRS-P0119804,6-Diaminopyrimidine-5-Carbaldehyde
CUSTOM SYNTHESISRS-U211LH94-Aminopyrazolo[3,4-d]pyrimidine
IN STOCKRS-U0891265-Amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide
IN STOCKRS-U0895905-Methyl-N,N diphenylpyridin-2-amine
IN STOCKRS-U0850705-methyl-N-phenyl-2-aminopyridine
CUSTOM SYNTHESISRS-U0851586-Chloro-1H-pyrazolo[3,4-b]pyrazine
IN STOCKRS-C003013Ibrutinib-biotin
CUSTOM SYNTHESISRS-I024026Ibrutinib-d5
IN STOCKRS-I003106N-Nitroso (S)-Piperidin-3-ol
IN STOCKRS-N001344N-Piperidine ibrutinib hydrochloride
BACK ORDERRS-I024073Remibrutinib(LOU064)
BACK ORDERRS-U080593tert-Butyl (R)-3-(4-amino-3-bromo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
CUSTOM SYNTHESISRS-Z398SY1tert-Butyl 3-bromo-4-hydroxy-1H-pyrazolo[3,4-d]pyrimidine-1-carboxylate
IN STOCKRS-Z399IIJIbrutinib Impurity 7
IN STOCKRS-I001BGEIbrutinib Impurity 8
IN STOCKRS-I024015Zanubrutinib Impurity 9
BACK ORDERRS-Z412OH5Ibrutinib Impurity 18(Hydrochloride)
CUSTOM SYNTHESISRS-I024025Ibrutinib Impurity 19
BACK ORDERRS-I024587Ibrutinib Impurity 20-d9
IN STOCKRS-I024327Ibrutinib Impurity 38
BACK ORDERRS-I001APXIbrutinib Impurity 39
CUSTOM SYNTHESISRS-I001874Ibrutinib Impurity 48
CUSTOM SYNTHESISRS-Z412M9EIbrutinib Impurity 58-d8
CUSTOM SYNTHESISRS-I024322Ibrutinib Impurity 65
CUSTOM SYNTHESISRS-I001BOBIbrutinib Impurity 68
BACK ORDERRS-I001B5NIbrutinib Impurity 77
CUSTOM SYNTHESISRS-I001AAWIbrutinib Impurity 98
CUSTOM SYNTHESISRS-I024318Ibrutinib Impurity 110
IN STOCKRS-I024079Ibrutinib Impurity 113
BACK ORDERRS-I001AD5Ibrutinib Impurity 124
IN STOCKRS-I001B4LIbrutinib Impurity 129
IN STOCKRS-Z401GYPIbrutinib Impurity 137
CUSTOM SYNTHESISRS-I001A81Ibrutinib Impurity 144
IN STOCKRS-I001BEVIbrutinib Impurity 157
IN STOCKRS-I001AVYIbrutinib Impurity 164
BACK ORDERRS-I001B2YIbrutinib Impurity 182
IN STOCKRS-I024061Ibrutinib Impurity 183
IN STOCKRS-I024082Ibrutinib Impurity 194 (N-Nitroso Ibrutinib Impurity 44)
BACK ORDERRS-I024075Ibrutinib Impurity 199
IN STOCKRS-I024313Ibrutinib Impurity 201
IN STOCKRS-I024059Ibrutinib Impurity 219
IN STOCKRS-I024040Ibrutinib Impurity 222
IN STOCKRS-I024001Ibrutinib Impurity 223
IN STOCKRS-I024002Ibrutinib Impurity 224
IN STOCKRS-I024003Ibrutinib Impurity 225
IN STOCKRS-I024005Ibrutinib Impurity 226
IN STOCKRS-I024008Ibrutinib Impurity 227
IN STOCKRS-I024011Ibrutinib Impurity 228
IN STOCKRS-I024013Ibrutinib Impurity 229
BACK ORDERRS-I024017Ibrutinib Impurity 230
IN STOCKRS-I024021Ibrutinib Impurity 231
BACK ORDERRS-I024027Ibrutinib Impurity 232
IN STOCKRS-I024028Ibrutinib Impurity 233
IN STOCKRS-I024029Ibrutinib Impurity 234
BACK ORDERRS-I024030Ibrutinib Impurity 235
IN STOCKRS-I024031Ibrutinib Impurity 236
BACK ORDERRS-I024035Ibrutinib Impurity 237
BACK ORDERRS-I024038Ibrutinib Impurity 238
IN STOCKRS-I024041Ibrutinib Impurity 239
IN STOCKRS-I024042Ibrutinib Impurity 240
IN STOCKRS-I024043Ibrutinib Impurity 242
BACK ORDERRS-I024047Ibrutinib Impurity 243
BACK ORDERRS-I024049Ibrutinib Impurity 244
IN STOCKRS-I024051Ibrutinib Impurity 245
IN STOCKRS-I024053Ibrutinib Impurity 246
BACK ORDERRS-I024054Ibrutinib Impurity 247
BACK ORDERRS-I024056Ibrutinib Impurity 248
IN STOCKRS-I024057Ibrutinib Impurity 249
IN STOCKRS-I024062Ibrutinib Impurity 250
BACK ORDERRS-I024064Ibrutinib Impurity 251
BACK ORDERRS-I024065Ibrutinib Impurity 252
IN STOCKRS-I024066Ibrutinib Impurity 253
IN STOCKRS-I024069Ibrutinib Impurity 254
BACK ORDERRS-I024070Ibrutinib Impurity 255
IN STOCKRS-I024072Ibrutinib Impurity 256
IN STOCKRS-I024074Ibrutinib Impurity 257
IN STOCKRS-I024081Ibrutinib Impurity 279
CUSTOM SYNTHESISRS-I024315Ibrutinib Impurity 280
IN STOCKRS-I024319Ibrutinib Impurity 284
IN STOCKRS-I024332Ibrutinib Impurity 285
BACK ORDERRS-I024334Ibrutinib Impurity 289
BACK ORDERRS-I024338Ibrutinib Impurity 291
BACK ORDERRS-I024345Ibrutinib Impurity 294
BACK ORDERRS-I024349Ibrutinib Impurity 314
IN STOCKRS-U011043Ibrutinib Impurity 315
IN STOCKRS-U015055Ibrutinib Impurity 317
CUSTOM SYNTHESISRS-I024004Ibrutinib Impurity 318
IN STOCKRS-I024006Ibrutinib Impurity 319
CUSTOM SYNTHESISRS-I024007Ibrutinib Impurity 320
IN STOCKRS-I024009Ibrutinib Impurity 321
BACK ORDERRS-I024010Ibrutinib Impurity 322
IN STOCKRS-I024012Ibrutinib Impurity 323
IN STOCKRS-I024014Ibrutinib Impurity 324
IN STOCKRS-I024016Ibrutinib Impurity 325
IN STOCKRS-I024018Ibrutinib Impurity 327
BACK ORDERRS-I024020Ibrutinib Impurity 328
IN STOCKRS-I024022Ibrutinib Impurity 329
IN STOCKRS-I024023Ibrutinib Impurity 330
IN STOCKRS-I024024Ibrutinib Impurity 331
IN STOCKRS-I024032Ibrutinib Impurity 332
IN STOCKRS-I024033Ibrutinib Impurity 333
IN STOCKRS-I024034Ibrutinib Impurity 334
IN STOCKRS-I024036Ibrutinib Impurity 335
IN STOCKRS-I024037Ibrutinib Impurity 336
BACK ORDERRS-I024039Ibrutinib Impurity 337
IN STOCKRS-I024044Ibrutinib Impurity 338
IN STOCKRS-I024045Ibrutinib Impurity 341
IN STOCKRS-I024052Ibrutinib Impurity 342
BACK ORDERRS-I024055Ibrutinib Impurity 344
CUSTOM SYNTHESISRS-I024060Ibrutinib Impurity 345
IN STOCKRS-I024063Ibrutinib Impurity 347
CUSTOM SYNTHESISRS-I024071Ibrutinib Impurity 348
BACK ORDERRS-I024076Ibrutinib Impurity 349
IN STOCKRS-I024077Ibrutinib Impurity 350
CUSTOM SYNTHESISRS-I024078Ibrutinib Impurity 351
IN STOCKRS-I024080Ibrutinib Impurity 406
CUSTOM SYNTHESISRS-I024312Ibrutinib Impurity 407
IN STOCKRS-I024314Ibrutinib Impurity 408
IN STOCKRS-I024316Ibrutinib Impurity 409
IN STOCKRS-I024317Ibrutinib Impurity 410
BACK ORDERRS-I024320Ibrutinib Impurity 418
BACK ORDERRS-I024343Ibrutinib Impurity 421
IN STOCKRS-I024350Ibrutinib Impurity 512
IN STOCKRS-I027009Ibrutinib Impurity 513
IN STOCKRS-U003211Ibrutinib Impurity 514
BACK ORDERRS-U096676Ibrutinib Impurity 515
CUSTOM SYNTHESISRS-I024330Ibrutinib Impurity 516
IN STOCKRS-I024331
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.


![Chemical structure of (1R)-1-(1-Acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine 1-oxide](/structures/w4/WHNVUBNAXFVNTG-BQYWNOCXSA-N.webp?v=11)




![Chemical structure of (R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Dihydrochloride](/structures/w4/ZGTOUEKDPROJPB-UHFFFAOYSA-N.webp?v=11)


![Chemical structure of (S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/structures/w4/ATLAMSZMAHXMSQ-NTISSMGPSA-N.webp?v=11)

![Chemical structure of 1-((R)-3-(4-Amino-3-(4-(phenoxy-D5)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2,3-dihydroxypropan-1-one](/structures/w4/NWKPMPRXJGMTKQ-ROSSWGEHSA-N.webp?v=11)




![Chemical structure of 2-Propen-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-methyl-](/structures/w4/SVIZVWRMNNDHOC-LJQANCHMSA-N.webp?v=11)


![Chemical structure of 4-Aminopyrazolo[3,4-d]pyrimidine](/structures/w4/LHCPRYRLDOSKHK-UHFFFAOYSA-N.webp?v=11)



![Chemical structure of 6-Chloro-1H-pyrazolo[3,4-b]pyrazine](/structures/w4/PGTUKZWBYWVLHW-UHFFFAOYSA-N.webp?v=11)





![Chemical structure of tert-Butyl (R)-3-(3-(4-phenoxyphenyl)-4-((triphenyl-l5-phosphaneylidene)amino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate](/structures/w4/ARECIKOLCWUROL-UUWRZZSWSA-N.webp?v=11)
![Chemical structure of tert-Butyl (R)-3-(4-amino-3-bromo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate](/structures/w4/VHATZAIZPHOHET-SECBINFHSA-N.webp?v=11)
![Chemical structure of tert-Butyl 3-bromo-4-hydroxy-1H-pyrazolo[3,4-d]pyrimidine-1-carboxylate](/structures/w4/ZZMJFNPXSYBVMR-UHFFFAOYSA-N.webp?v=11)












































































































